TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,065 | -76.6% | 1,014 | -59.9% | 0.00% | – |
| Q2 2023 | $38,814 | +344.8% | 2,527 | +551.3% | 0.00% | – |
| Q1 2023 | $8,726 | -92.5% | 388 | -93.0% | 0.00% | – |
| Q4 2022 | $116,274 | -16.3% | 5,529 | -2.1% | 0.00% | – |
| Q3 2022 | $139,000 | +2.2% | 5,650 | 0.0% | 0.00% | – |
| Q2 2022 | $136,000 | -86.6% | 5,650 | -85.7% | 0.00% | -100.0% |
| Q1 2022 | $1,016,000 | -13.2% | 39,442 | +4.5% | 0.00% | 0.0% |
| Q4 2021 | $1,171,000 | – | 37,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 411,680 | $10,609,000 | 9.85% |
| VR Adviser, LLC | 1,994,997 | $51,411,000 | 8.33% |
| Kynam Capital Management, LP | 870,918 | $22,444,000 | 7.28% |
| GREAT POINT PARTNERS LLC | 1,010,000 | $26,028,000 | 6.29% |
| Deep Track Capital, LP | 3,134,503 | $80,776,000 | 5.18% |
| RA Capital Management | 4,922,941 | $126,864,000 | 2.77% |
| ARMISTICE CAPITAL, LLC | 4,958,000 | $127,768,000 | 2.47% |
| MPM BioImpact LLC | 277,950 | $7,163,000 | 1.92% |
| Sofinnova Investments, Inc. | 658,249 | $16,963,000 | 1.29% |
| Perceptive Advisors | 1,845,555 | $47,560,000 | 0.95% |